Articles mentioning Bristol-Myers Squibb (BMY)

Results 11 - 20 of 888 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY

Investing | February 21, 2017

Factor Xa's Win Billions of Dollars in Sales From Warfarin

The latest innovation in blood thinners could make investors heart-stopping profits.

Investing | February 16, 2017

How Bristol-Myers Squibb and Pfizer Are Winning a Big Brawl in Blood Thinners

Despite competition from Johnson & Johnson's Xarelto, Bristol-Myers Squibb and Pfizer's Eliquis is dominating the market for factor Xa inhibitors.

Investing | February 14, 2017

3 Stocks We're Watching in the First Quarter

Our Foolish contributors are keeping a close eye on Bristol-Myers Squibb, Gilead Sciences, and Lexicon Pharmaceuticals in the first quarter of 2017.

Investing | February 13, 2017

Better Buy: Exelixis, Inc. vs. Bristol-Myers Squibb

Is small Exelixis a better stock pick for investors than big Bristol-Myers Squibb?

Investing | February 06, 2017

These 2 Factors Sent Bristol-Myers Squibb Co. Tumbling by 16% in January

All finger-pointing begins and ends with cancer immunotherapy Opdivo.

Investing | January 31, 2017

Merck Makes Nice With Bristol-Myers Squibb

A major patent settlement between Merck & Co. and Bristol-Myers Squibb was one of last week's biggest healthcare stories.

Investing | January 31, 2017

7 Top Stocks to Buy in February

Our team of Foolish contributors thinks these seven stocks are all strong buys right now.

Investing | January 30, 2017

News! News! News! Here's What's Happened in Healthcare Last Week

From a big-time patent settlement between Merck & Co. and Bristol-Myers Squibb, to Johnson & Johnson's earnings, to Aetna and Humana's $37 billion merger bust, we dive into the details behind last week's biggest healthcare stories.

Investing | January 30, 2017

3 Deeply Discounted Value Stocks on Sale This Winter

These cheap stocks could be money in your pocket over the long term.

Investing | January 27, 2017

3 Companies Putting the Squeeze on Bristol-Myers Squibb

Bristol-Myers Squibb's executives acknowledge stiff competition from Merck, Roche, and Gilead Sciences.

Results 11 - 20 of 888 : Previous 1 2 3 4 5 6 7 8 9 Next

Get RSS Feed for BMY


Advertisement